๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Identification of novel regions of altered DNA copy number in small cell lung tumors

โœ Scribed by Nikki A. Levin; Piur M. Bnorka; Martha L. Warnock; Joe W. Gray; Michael F. Christman


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
911 KB
Volume
13
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Identification of the genetic alterations that occur in tumors is an important approach to understanding tumorigenesis. We have used comparative genomic hybridization (CGH), a novel molecular cytogenetic method, to identify the gross DNA copy number changes that commonly occur in small cell lung cancer (SCLC). We analyzed ten SCLC tumors (seven primary tumors and three metastases) from eight patients. We found frequent increases in DNA copy number on chromosome arms Sp, 8q, 3q, and Xq and frequent decreases in copy number on chromosome arms 3p. 17p, Sq, 8p, 13q, and 4p. The increase in copy number at 8q24 (MYC) and decreases at 17p 13 (TP53), 13q 14 (RB), and 3p have previously been identified in SCLC with other methods. Many of the other regions in which we detected common copy number changes have not been reported to be regions of common alteration in SCLC tumors. Comparison of copy number changes between a primary tumor and a metastasis from the same patient showed that they were more closely related to each other than to any of the other tumors. The results of direct CGH analysis of SCLC tumors reported here confirm the existence of copy number changes that we identified previously by using cell lines. ยฉ 1995 Wileyโ€Liss, Inc.


๐Ÿ“œ SIMILAR VOLUMES


Distinct patterns of DNA copy number alt
โœ J. Greshock; K. Nathanson; A. Medina; M. R. Ward; M. Herlyn; B. L. Weber; T. Z. ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 301 KB ๐Ÿ‘ 1 views

## Abstract A majority of malignant melanomas harbor an oncogenic mutation in either __BRAF__ or __NRAS__. If __BRAF__ and __NRAS__ transform melanoma cells by a similar mechanism, then additional genetic aberrations would be similar (or random). Alternatively, distinct mutationโ€associated changes

Identification of postoperative adjuvant
โœ Takashi Hirano; Harubumi Kato; Masahiro Maeda; Yunbo Gong; Yanning Shou; Miho Na ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 491 KB

## Abstract Cisplatinโ€based (CDDPโ€based) adjuvant chemotherapy of nonโ€small cell lung cancer (NSCLC) was reported to yield 5โ€“15% improvement in 5โ€year survival compared to complete resection alone. The importance of information concerning preselection of good responders has become increasingly evid

Correlation between encoded protein over
โœ Haruhiko Nakamura; Hisashi Saji; Akihiko Ogata; Makoto Hosaka; Masaru Hagiwara; ๐Ÿ“‚ Article ๐Ÿ“… 2002 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 305 KB ๐Ÿ‘ 1 views

## Abstract The __HER2__ oncogene, which encodes the tyrosine kinase receptor, is commonly overexpressed in several types of cancer. Treatment using a humanized monoclonal antibody bound to __HER2__ product is becoming standard therapy for advanced breast cancer. Overexpression occurs in approximat

Genome-wide high-resolution analysis of
โœ Kiran K. Mantripragada; Teresita Dรญaz de Stรฅhl; Chris Patridge; Uwe Menzel; Robi ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 517 KB

## Abstract Neurofibromatosis Type I (NF1) is an autosomal dominant disorder characterized by the development of both benign and malignant tumors. The lifetime risk for developing a malignant peripheral nerve sheath tumor (MPNST) in NF1 patients is โˆผ10% with poor survival rates. To date, the molecu